ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB) had a decrease of 46.91% in short interest. ENTB’s SI was 23,200 shares in April as released by FINRA. Its down 46.91% from 43,700 shares previously. With 186,800 avg volume, 0 days are for ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB)’s short sellers to cover ENTB’s short positions. The stock decreased 11.21% or $0.0048 on April 6, reaching $0.038. About 13,110 shares traded. Entest Biomedical Inc (OTCMKTS:ENTB) has risen 347.06% since September 8, 2016 and is uptrending. It has outperformed by 338.47% the S&P500.
Above from April 7, 2017 - By Stephen Andrade-Herald KS
